<PAGE> 1
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. __1___)
Securities and Exchange Commission
Washington, D.C. 20549
CONTOUR MEDICAL, INC.
(Name of Issuer)
Common 21220B105
(Title of Class of Securities) (CUSIP Number)
Vance M. Arnold, Executive Vice President, Renaissance Capital Group, Inc.
8080 N. Central Expressway, Suite 210 LB 59; Dallas, TX 75206
(214) 891-8294
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
December 31, 1997
(Date of Event which Requires Filing of this Statement)
<PAGE>
<PAGE> 2
1. Names of Reporting Person S.S. or I.R.S. Identification No.
a. Renaissance Capital Growth & Income Fund III, Inc. 75-2533518
b. Renaissance US Growth & Income Trust PLC
2. Check the Appropriate Box if a Member of a Group
(a) XX
(b)
3. SEC Use Only____________________________________________________
4. Source of Funds PF
5. Check if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or 2(e) None
6. Citizenship or Place of Organization
a. Texas b. England
Number of Shares Beneficially Owned by Each Reporting Person With:
(7) Sole voting Power 0
(8) Shared Voting Power 0
(9) Sole Dispositive Power 0
(10) Shared Dispositive Power 0
11. Aggregate Amount Beneficially Owned be Each Reporting Person 0
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares None
13. Percent of Class Represented by Amount in Row (11) 0%
14. Type of Reporting Person IV
<PAGE>
<PAGE> 3
AMENDED SCHEDULE 13D
Filed Pursuant to Rule 13D-1
Item 1. Security and Issuer
$2,500,000 9.0% Convertible Debenture by and between Contour Medial,
Inc. as Borrower and Renaissance Capital Growth & Income Fund III, Inc.
as Lender.
$2,500,000 9.0% Convertible Debenture by and between Contour Medial,
Inc. as Borrower and Renaissance U.S. Growth & Income Trust, PLC as
Lender.
Contour Medical, Inc. Company
6025 Shiloh Road
Alpharetta, GA 30005
Item 2. Identity and Background
a,b,c Renaissance Capital Growth &
Income Fund III, Inc. Filer
8080 N. Central Expressway, Suite 210
Dallas, Texas 75206
Renaissance U.S. Growth & Income
Trust, PLC Filer
8080 N. Central Expressway, Suite 210
Dallas, Texas 75206
Renaissance Capital Group, Inc.Investment Advisor to the Filers
8080 N. Central Expressway, Suite 210
Dallas, Texas 75206
Renaissance Capital Growth & Income Fund III, Inc. is a Texas
corporation, organized as a business development company under the
Investment Company Act of 1940 and is traded on the Nasdaq.
Renaissance U.S. Growth & Income Trust, PLC is a public limited
company organized under the laws of England and Wales and traded on
the London Stock Exchange.
The officers of Renaissance Capital Group, Inc. are:
Russell Cleveland, President
Barbe Butschek, Senior Vice President,
Corporate Secretary and Treasurer
Vance M. Arnold, Executive Vice President
Robert C. Pearson, Senior Vice President
Norman D. Cox, Vice President
Mardon M. Navalta, Vice President
John A. Schmit, Vice President
<PAGE>
<PAGE> 4
Renaissance Capital Group, Inc. a Texas corporation, is the
Investment Advisor and is responsible for the administration and
investment of the Filer's investment portfolio. Renaissance
Capital Group, Inc. has a profit interest of up to 20% of the
Filer's capital gains.
d. None
e. None
f. Texas
Item 3. Source and Amount of Funds or Other Consideration
The Filer's source of funds for this transaction came exclusively from
the Filer's investment capital. No borrowed funds were used in the
transaction. The securities were acquired directly from the Company in
a private placement.
Item 4. Purpose of Transaction
The purpose of the acquisition of these securities for Renaissance
Capital Growth & Income Fund III, Inc. was as an investment in
accordance with its election as a Business Development Company under the
Investment Act of 1940. The purpose of the acquisition of these
securities for Renaissance U.S. Growth & Income Trust, PLC was as an
investment in accordance with its investment strategy of investing in
smaller United States public companies.
Item 5. Interest in Securities of the Issuer
a. The Filer s each purchased on July 12, 1996 a 9% Convertible
Debenture for $2.5 million in the Company, convertible at $5.00 per
share. The Debenture will mature July 1, 2003. Shares of issuer
beneficially owned by Renaissance Capital Growth & Income Fund III,
Inc. number 500,000 and the shares beneficially owned by
Renaissance US Growth & Income Trust PLC also number 500,000. The
total number of shares beneficially owned by both Filers combined
represent 10.96% of the Company s outstanding stock. These shares
represent all of the Filer s ownership. Renaissance Capital Group,
Inc. has a profit interest of up to 20%.
b. All the shares mentioned in (a) above.
c. On December 31, 1997, both Filer s sold their entire position in
the Company to Sun HealthCare Group, Inc. for $8.4 million.
d. N/A
e. Both Filer s ceased to be beneficial owners of more than five
percent of the Company on December 31, 1997.
<PAGE>
<PAGE> 5
Item 6. Contracts, Arrangements, or Understandings with Respect to Securities
of the Issuer
The Company and the Filers entered into Convertible Debenture Loan
Agreements on July 12, 1996. Said documents contain default and other
provisions contained in loan agreements more generally. As mentioned in
the previous item, the Convertible Debenture Loan Agreements grant the
Filer the option to name a board of director to the Company. The
Investment Advisor of the Filer has a profit interest of up to 20% of
the profits of the Filer.
Item 7. Persons Retained, Employed or to be Compensated
Not Applicable
Item 8. Material to be Filed as Exhibits
Not Applicable
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
Date: January 20, 1998
By: Renaissance US Growth & Income Trust, PLC
Renaissance Capital Group, Inc., Investment Advisor
By: _________/S/_______________________
Vance M. Arnold
Executive Vice President
By: Renaissance US Growth & Income Trust, PLC
Renaissance Capital Group, Inc., Investment Manager
By: _______/S/_________________________
Vance M. Arnold
Executive Vice President
<PAGE>
